E-cadherin Stem Cell Isolation and HC-HA Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and expanding stem cells, such as from amniotic membrane and umbilical cord tissues, face challenges in achieving high purity and yield due to contamination and inefficient expansion techniques, which limit their application in regenerative therapies.
Innovation Solution
The methods involve isolating E-cadherin positive stem cells using agents that bind to E-cadherin and expanding them on substrates containing a hyaluronan (HA) and heavy chain of inter-α-inhibitor (HC) complexes, which promote aggregation and maintain pluripotency, reducing differentiation and preserving stem cell markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional isolation methods are used to obtain stem cells from mixed cell populations, then the isolation process is simple, but the purity and yield of stem cells are low due to contamination and inefficient separation
Solution Approach 1:
The patent uses fluorescence-activated cell sorting (FACS) which relies on fluorescent markers to identify and separate E-cadherin positive stem cells from mixed cell populations. The fluorescent labeling allows for precise identification and sorting of target cells based on their E-cadherin expression, thereby achieving high purity and yield without overly complicating the isolation process
Solution Approach 2:
The patent replaces conventional mechanical separation methods with magnetic-activated cell sorting (MACS) using antibodies conjugated to magnetic beads. This substitution allows for more efficient and specific isolation of E-cadherin positive stem cells based on their surface markers, significantly improving purity and yield while maintaining process feasibility
2Productivity
If stem cells are expanded using conventional culture methods, then the expansion process is straightforward, but the stem cells undergo differentiation and lose pluripotency
Solution Approach 1:
The patent introduces HC-HA complexes as an intermediary substrate for stem cell expansion. These complexes, composed of hyaluronic acid and heavy chain proteins, serve as a specialized extracellular matrix that maintains stem cell pluripotency while supporting efficient expansion. The HC-HA complexes mediate cell-substrate interactions that prevent differentiation, allowing high productivity without loss of stem cell characteristics
Solution Approach 2:
The patent modifies the culture substrate parameters by using HC-HA complexes with specific molecular weights and compositions. This parameter change in the culture environment creates optimal conditions for maintaining E-cadherin expression and pluripotency markers while enabling efficient cell expansion, thereby resolving the contradiction between productivity and stability
3Manufacturing precision
If E-cadherin positive cells are isolated using binding agents, then the isolation specificity is high, but the process requires additional reagents and steps
Solution Approach 1:
The patent extracts and utilizes the natural E-cadherin protein as the isolation target, employing antibodies specific to E-cadherin for binding and separation. By focusing on this specific surface marker that is naturally present on the stem cells, the method achieves high isolation specificity without requiring complex multi-step protocols, as the E-cadherin antibody binding directly identifies and isolates the target cell population
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods enhance the purity and expansion of stem cells, allowing for their effective use in regenerative therapies by maintaining pluripotency and preventing differentiation, thereby improving the yield and quality of stem cell populations.
Implementation Method 1
contacting the remaining umbilical cord tissue with collagenase for a period of time sufficient to separate one or more stem cells from other bound cells and components of the stromal matrix
Implementation Method 2
fractionating the collagenase-digested adipose tissue by centrifugation, thereby producing a floating cell fraction (FC) and a sedimented stromal vascular fraction (SVF)
Implementation Method 3
contacting a mixed cell population comprising one or more stem cells with an agent that binds to E-cadherin, thereby isolating an E-cadherin positive stem cell
Implementation Method 4
expanding them on substrates containing a hyaluronan (HA) and heavy chain of inter-α-inhibitor (HC) complexes, which promote aggregation and maintain pluripotency
Data Source
AI summary
Provided herein are methods of isolating and expanding a plurality of multipotent stem cells. Also described are methods of expanding stem cells on a substrate comprising an HC-HA complex. Also described are isolated and expanded stem cells produced by the methods and uses thereof, including stem cell therapy, as niche cells for supporting other types of stem cells, or as bioreactors for the production of HC-HA complexes. Also described are uses of HC-HA complexes as a carrier for stem cells.